EN3001 / Enosi - LARVOL DELTA

Structural assessment of the gripper interlock of the DEMO breeding blanket transporter. (PubMed, Heliyon) - "The work discussed here concerns the structural analysis conducted on the gripper interlock; its structural integrity has been checked against the most severe load conditions that include also seismic loads according to the EN13001...The effect of the gap sizes at the contact surfaces between gripper interlock and BB after engagement as well as the effect of different friction coefficients on the sliding areas were assessed. The improvements of the design based on the structural analysis are presented, too."

Journal

"#EnosiLifeSciences Files #Patent for #TNFInhibiting Molecules #EN1001, #EN2001 and #EN3001 https://t.co/rGAq8k45b6" (@1stOncology)

Enosi Life Sciences Files Patent for TNF-Inhibiting Molecules EN1001, EN2001 and EN3001 (GlobeNewswire) - "Enosi Life Sciences Corp...announced it has filed a patent for its proprietary molecules. These include EN1001 for autoimmune disease; EN2001 for autoimmune disease and cancer; and EN3001 for autoimmune disease and cancer....The EN1001 molecule blocks Tumor Necrosis Factor Receptor-1 (TNFR1), which is a principal culprit in autoimmune disease, acute inflammation and has a role in cancer."

Patent • Oncology • Solid Tumor